Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Antifungal drugs and the risk of selected birth defects.

Carter TC, Druschel CM, Romitti PA, Bell EM, Werler MM, Mitchell AA; National Birth Defects Prevention Study.

Am J Obstet Gynecol. 2008 Feb;198(2):191.e1-7. doi: 10.1016/j.ajog.2007.08.044.

PMID:
18226621
2.

Exposure to fluconazole and risk of congenital malformations in the offspring: A systematic review and meta-analysis.

Alsaad AM, Kaplan YC, Koren G.

Reprod Toxicol. 2015 Apr;52:78-82. doi: 10.1016/j.reprotox.2015.02.009. Epub 2015 Feb 25. Review.

PMID:
25724389
3.

[Fluconazole administration during pregnancy].

Albukrek D, Davidson S, Merlob P.

Harefuah. 1998 Sep;135(5-6):243-6. Review. Hebrew. No abstract available.

PMID:
9885646
4.

Teratogenicity risk of antiretroviral therapy in pregnancy.

Watts DH.

Curr HIV/AIDS Rep. 2007 Aug;4(3):135-40. Review.

PMID:
17883999
5.

Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.

Ford N, Calmy A, Mofenson L.

AIDS. 2011 Nov 28;25(18):2301-4. doi: 10.1097/QAD.0b013e32834cdb71. Review.

PMID:
21918421
6.

Maternal occupational exposure and risk of specific birth defects.

Thulstrup AM, Bonde JP.

Occup Med (Lond). 2006 Dec;56(8):532-43. Review.

PMID:
17151389
7.

Selected environmental risk factors and congenital heart defects.

Kuciene R, Dulskiene V.

Medicina (Kaunas). 2008;44(11):827-32. Review.

8.

Epidemiology of birth defects.

Janerich DT, Polednak AP.

Epidemiol Rev. 1983;5:16-37. Review. No abstract available.

PMID:
6357820
9.

Maternal drugs and congenital heart disease.

Zierler S.

Obstet Gynecol. 1985 Feb;65(2):155-65. Review.

PMID:
3881709
10.

Vulvovaginal candidiasis.

Marrazzo J.

Clin Evid. 2002 Jun;(7):1784-96. Review. No abstract available. Update in: Clin Evid. 2003 Jun;(9):1980-93.

PMID:
12230789
11.

Drug exposure in pregnancy and heart defects.

Matok I, Pupco A, Koren G.

J Cardiovasc Pharmacol. 2011 Jul;58(1):20-4. doi: 10.1097/FJC.0b013e31821c471b. Review.

PMID:
21499119
12.

Epidemiology of cardiovascular malformations: prevalence and risk factors.

Loffredo CA.

Am J Med Genet. 2000 Winter;97(4):319-25. Review.

PMID:
11376444
13.

Application of pharmacogenomic strategies to the study of drug-induced birth defects.

Leeder JS, Mitchell AA.

Clin Pharmacol Ther. 2007 Apr;81(4):595-9. Epub 2007 Feb 21. Review.

PMID:
17314924
14.

Coccidioidomycosis in pregnancy: case report and review of the literature.

Crum NF, Ballon-Landa G.

Am J Med. 2006 Nov;119(11):993.e11-7. Review.

PMID:
17071170
15.

Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls.

Hackshaw A, Rodeck C, Boniface S.

Hum Reprod Update. 2011 Sep-Oct;17(5):589-604. doi: 10.1093/humupd/dmr022. Epub 2011 Jul 11. Review.

16.
17.

[Congenital defects and drugs of noninstitutional use].

Villalbí JR.

Med Clin (Barc). 1999 Jan 23;112(2):57-8. Review. Spanish. No abstract available.

PMID:
10065431
18.

Congenital heart defects and maternal fever: systematic review and meta-analysis.

Shi QY, Zhang JB, Mi YQ, Song Y, Ma J, Zhang YL.

J Perinatol. 2014 Sep;34(9):677-82. doi: 10.1038/jp.2014.76. Epub 2014 May 8. Review.

PMID:
24811224
19.

Getting to the heart of the matter: epidemiology of cyanotic heart defects.

Kornosky JL, Salihu HM.

Pediatr Cardiol. 2008 May;29(3):484-97. doi: 10.1007/s00246-007-9185-9. Epub 2008 Jan 10. Review.

PMID:
18185949
20.

[Leflunomide: assessing teratogenic risk during the first trimester of pregnancy].

Casanova Sorní C, Romá Sánchez E, Pelufo Pellicer A, Poveda Andrés JL.

Farm Hosp. 2005 Jul-Aug;29(4):265-8. Review. Spanish.

Supplemental Content

Support Center